Page 1 of Clinical Trials for Metabolic Solutions Development Company [SPONSOR-COLLABORATORS], 4 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone™ (MSDC-0160) in Type 2 Diabetic Patients
Last Updated: April 18, 2012
Condition(s): Type 2 Diabetes
2
Recruiting
3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease
Last Updated: November 4, 2011
Condition(s): Alzheimer's Disease
3
Completed
A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator
Last Updated: May 11, 2009
Condition(s): Type 2 Diabetes Mellitus
4
Completed
A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSCD-0602 in Type 2 Diabetic Patients
Last Updated: November 3, 2011
Condition(s): Diabetes Mellitus, Type 2

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Metabolic+Solutions+Development+Company

Page 1 of Clinical Trials for Metabolic Solutions Development Company [SPONSOR-COLLABORATORS], 4 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About